BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33582217)

  • 21. Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine.
    Chu HF; Chen CC; Moses DC; Chen YH; Lin CH; Tsai YC; Chou CY
    Antiviral Res; 2018 Oct; 158():199-205. PubMed ID: 30138642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin specific peptidase 21 regulates interleukin-8 expression, stem-cell like property of human renal cell carcinoma.
    Peng L; Hu Y; Chen D; Jiao S; Sun S
    Oncotarget; 2016 Jul; 7(27):42007-42016. PubMed ID: 27259257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation.
    Hou P; Ma X; Zhang Q; Wu CJ; Liao W; Li J; Wang H; Zhao J; Zhou X; Guan C; Ackroyd J; Jiang S; Zhang J; Spring DJ; Wang YA; DePinho RA
    Genes Dev; 2019 Oct; 33(19-20):1361-1366. PubMed ID: 31488580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer.
    Arceci A; Bonacci T; Wang X; Stewart K; Damrauer JS; Hoadley KA; Emanuele MJ
    Cell Rep; 2019 Mar; 26(11):3076-3086.e6. PubMed ID: 30865895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69.
    Gousseva N; Baker RT
    Gene Expr; 2003; 11(3-4):163-79. PubMed ID: 14686789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins.
    Gong L; Kamitani T; Millas S; Yeh ET
    J Biol Chem; 2000 May; 275(19):14212-6. PubMed ID: 10799498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
    Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
    Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.
    Choi J; Lee YM; Jee JG
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of active site residues to substrate hydrolysis by USP2: insights into catalysis by ubiquitin specific proteases.
    Zhang W; Sulea T; Tao L; Cui Q; Purisima EO; Vongsamphanh R; Lachance P; Lytvyn V; Qi H; Li Y; Ménard R
    Biochemistry; 2011 May; 50(21):4775-85. PubMed ID: 21542621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a highly reliable assay for ubiquitin-specific protease 2 inhibitors.
    Wang Z; Xie W; Zhu M; Zhou H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4015-4018. PubMed ID: 28778469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Bronopol and Disulfiram as Potential
    Nan J; Zhang S; Zhan P; Jiang L
    Molecules; 2020 May; 25(10):. PubMed ID: 32423116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade.
    Wang Y; Jiang Y; Ding S; Li J; Song N; Ren Y; Hong D; Wu C; Li B; Wang F; He W; Wang J; Mei Z
    Cell Res; 2018 Dec; 28(12):1186-1194. PubMed ID: 30254335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of ubiquitin recognition by the deubiquitinating protease USP2.
    Renatus M; Parrado SG; D'Arcy A; Eidhoff U; Gerhartz B; Hassiepen U; Pierrat B; Riedl R; Vinzenz D; Worpenberg S; Kroemer M
    Structure; 2006 Aug; 14(8):1293-302. PubMed ID: 16905103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models.
    Davis MI; Pragani R; Fox JT; Shen M; Parmar K; Gaudiano EF; Liu L; Tanega C; McGee L; Hall MD; McKnight C; Shinn P; Nelson H; Chattopadhyay D; D'Andrea AD; Auld DS; DeLucas LJ; Li Z; Boxer MB; Simeonov A
    J Biol Chem; 2016 Nov; 291(47):24628-24640. PubMed ID: 27681596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic enhancement of 6-thioguanine cytotoxicity by ADP-ribosyltransferase inhibitors.
    Moses K; Harris AL; Durkacz BW
    Cancer Res; 1988 Oct; 48(20):5650-4. PubMed ID: 3139280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Ubiquitin-Specific Proteases as a Novel Anticancer Therapeutic Strategy.
    Yuan T; Yan F; Ying M; Cao J; He Q; Zhu H; Yang B
    Front Pharmacol; 2018; 9():1080. PubMed ID: 30319415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.
    Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C
    Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.
    Kitamura H; Hashimoto M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
    Li W; Cui K; Prochownik EV; Li Y
    Cell Death Dis; 2018 May; 9(5):482. PubMed ID: 29706623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation.
    Pannu J; Belle JI; Förster M; Duerr CU; Shen S; Kane L; Harcourt K; Fritz JH; Clare S; Nijnik A
    PLoS One; 2015; 10(2):e0117304. PubMed ID: 25680095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.